Why the study?
Does intravenous dobutamine alter hemodynamic and myocardial metabolic parameters in patients with congestive heart failure secondary to coronary artery disease?
Population
15 patients with congestive heart failure secondary to coronary artery disease
Design
Case_series
Authors
Loading...
Higher dobutamine doses may induce ischemia in ischemic HF; leaves open optimal dosing strategies pending prospective studies.
Does intravenous dobutamine alter hemodynamic and myocardial metabolic parameters in patients with congestive heart failure secondary to coronary artery disease?
Higher doses of dobutamine (10 μg/kg/min) in patients with ischemic heart failure can increase heart rate and myocardial oxygen demand beyond supply, precipitating myocardial ischemia.
Küpper et al. (1982) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: